Methods to monitor distribution and metabolic activity of mesenchymal stem cells following in vivo injection into nucleotomized porcine intervertebral discs.

PubWeight™: 0.93‹?›

🔗 View Article (PMC 2899826)

Published in Eur Spine J on December 29, 2009

Authors

G W Omlor1, H Bertram, K Kleinschmidt, J Fischer, K Brohm, T Guehring, M Anton, Wiltrud Richter

Author Affiliations

1: Division of Experimental Orthopaedics, Orthopaedic University Hospital Heidelberg, Schlierbacher Landstrasse 200a, 69118 Heidelberg, Germany.

Articles citing this

Injectable laminin-functionalized hydrogel for nucleus pulposus regeneration. Biomaterials (2013) 1.01

Organ culture bioreactors--platforms to study human intervertebral disc degeneration and regenerative therapy. Curr Stem Cell Res Ther (2015) 0.91

Bioactive electrospun scaffold for annulus fibrosus repair and regeneration. Eur Spine J (2012) 0.88

Cell sources for nucleus pulposus regeneration. Eur Spine J (2013) 0.82

Injection of a polymerized hyaluronic acid/collagen hydrogel matrix in an in vivo porcine disc degeneration model. Eur Spine J (2012) 0.82

A needle micro-osmometer for determination of glycosaminoglycan concentration in excised nucleus pulposus tissue. Eur Spine J (2013) 0.82

Cell-Based Therapies Used to Treat Lumbar Degenerative Disc Disease: A Systematic Review of Animal Studies and Human Clinical Trials. Stem Cells Int (2015) 0.80

Short-term follow-up of disc cell therapy in a porcine nucleotomy model with an albumin-hyaluronan hydrogel: in vivo and in vitro results of metabolic disc cell activity and implant distribution. Eur Spine J (2014) 0.79

The correlation between microvessel pathological changes of the endplate and degeneration of the intervertebral disc in diabetic rats. Exp Ther Med (2012) 0.77

Disc cell therapies: critical issues. Eur Spine J (2014) 0.76

The role of stem cell therapies in degenerative lumbar spine disease: a review. Neurosurg Rev (2015) 0.76

Autologous transplantation of CD34(+) bone marrow derived mononuclear cells in management of non-reconstructable critical lower limb ischemia. Cytotechnology (2014) 0.75

Minimal invasive annulotomy for induction of disc degeneration and implantation of poly (lactic-co-glycolic acid) (PLGA) plugs for annular repair in a rabbit model. Eur J Med Res (2016) 0.75

Bioluminescence-mediated longitudinal monitoring of adipose-derived stem cells in a large mammal ex vivo organ culture. Sci Rep (2015) 0.75

Articles cited by this

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res (1987) 24.27

Lumbar disc disorders and low-back pain: socioeconomic factors and consequences. J Bone Joint Surg Am (2006) 5.56

Long-term outcomes of surgical and nonsurgical management of lumbar spinal stenosis: 8 to 10 year results from the maine lumbar spine study. Spine (Phila Pa 1976) (2005) 3.67

Long-term outcomes of surgical and nonsurgical management of sciatica secondary to a lumbar disc herniation: 10 year results from the maine lumbar spine study. Spine (Phila Pa 1976) (2005) 3.17

Clinical outcomes after lumbar discectomy for sciatica: the effects of fragment type and anular competence. J Bone Joint Surg Am (2003) 3.14

Are animal models useful for studying human disc disorders/degeneration? Eur Spine J (2007) 2.82

The tensile properties of the cartilage of human femoral condyles related to the content of collagen and glycosaminoglycans. Biochim Biophys Acta (1973) 2.81

Factors involved in the nutrition of the human lumbar intervertebral disc: cellularity and diffusion of glucose in vitro. J Anat (1975) 2.53

Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone (1992) 2.39

Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression. Proc Natl Acad Sci U S A (2009) 2.18

Mechanobiology of the intervertebral disc and relevance to disc degeneration. J Bone Joint Surg Am (2006) 1.96

Animal models of intervertebral disc degeneration: lessons learned. Spine (Phila Pa 1976) (2004) 1.93

Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration. Spine (Phila Pa 1976) (2005) 1.91

Current understanding of cellular and molecular events in intervertebral disc degeneration: implications for therapy. J Pathol (2002) 1.81

Regenerative effects of transplanting mesenchymal stem cells embedded in atelocollagen to the degenerated intervertebral disc. Biomaterials (2005) 1.79

Intradiscal administration of osteogenic protein-1 increases intervertebral disc height and proteoglycan content in the nucleus pulposus in normal adolescent rabbits. Spine (Phila Pa 1976) (2005) 1.68

Nutrient supply and intervertebral disc metabolism. J Bone Joint Surg Am (2006) 1.57

Autologous intervertebral disc cell implantation: a model using Psammomys obesus, the sand rat. Spine (Phila Pa 1976) (2002) 1.50

Clinical experience in cell-based therapeutics: disc chondrocyte transplantation A treatment for degenerated or damaged intervertebral disc. Biomol Eng (2006) 1.49

2004 Young Investigator Award Winner: vertebral endplate marrow contact channel occlusions and intervertebral disc degeneration. Spine (Phila Pa 1976) (2005) 1.46

Feasibility of a stem cell therapy for intervertebral disc degeneration. Spine J (2007) 1.44

Effect of aging and degeneration on disc volume and shape: A quantitative study in asymptomatic volunteers. J Orthop Res (2006) 1.41

The cost-utility of lumbar disc herniation surgery. Eur Spine J (2006) 1.35

Notochordal intervertebral disc cells: sensitivity to nutrient deprivation. Arthritis Rheum (2009) 1.30

Intervertebral disk calcification of the spine in an elderly population: radiographic prevalence, location, and distribution and correlation with spinal degeneration. Radiology (2004) 1.29

Transplantation of human mesenchymal stems cells into intervertebral discs in a xenogeneic porcine model. Spine (Phila Pa 1976) (2009) 1.26

Biological treatment strategies for disc degeneration: potentials and shortcomings. Eur Spine J (2006) 1.25

Autocrine/paracrine mechanism of insulin-like growth factor-1 secretion, and the effect of insulin-like growth factor-1 on proteoglycan synthesis in bovine intervertebral discs. J Orthop Res (1996) 1.23

Comparative morphometry of L4 vertebrae: comparison of large animal models for the human lumbar spine. Spine (Phila Pa 1976) (2002) 1.23

Bone mesenchymal stem cells transplanted into rabbit intervertebral discs can increase proteoglycans. Clin Orthop Relat Res (2005) 1.23

An experimental study of the regeneration of the intervertebral disc with an allograft of cultured annulus fibrosus cells using a tissue-engineering method. Spine (Phila Pa 1976) (2003) 1.20

Molecular biology of degenerative disc disease. Neurosurgery (2000) 1.20

Iron oxide labelling of human mesenchymal stem cells in collagen hydrogels for articular cartilage repair. Biomaterials (2007) 1.16

Is a collagen scaffold for a tissue engineered nucleus replacement capable of restoring disc height and stability in an animal model? Eur Spine J (2006) 1.15

Minimally invasive techniques for the management of lumbar disc herniation. Orthop Clin North Am (2007) 1.14

Pharmacological enhancement of disc diffusion and differentiation of healthy, ageing and degenerated discs : Results from in-vivo serial post-contrast MRI studies in 365 human lumbar discs. Eur Spine J (2008) 1.12

ISSLS prize winner: A novel approach to determine trunk muscle forces during flexion and extension: a comparison of data from an in vitro experiment and in vivo measurements. Spine (Phila Pa 1976) (2003) 1.08

A longitudinal study of the matrix changes induced in the intervertebral disc by surgical damage to the annulus fibrosus. J Orthop Res (1992) 1.07

Biomechanical evaluation of conventional anulus fibrosus closure methods required for nucleus replacement. Laboratory investigation. J Neurosurg Spine (2008) 1.06

The leakage pathway and effect of needle gauge on degree of disc injury post anular puncture: a comparative study using aged human and adolescent porcine discs. Spine (Phila Pa 1976) (2007) 1.06

Mesenchymal stem cell differentiation in an experimental cartilage defect: restriction of hypertrophy to bone-close neocartilage. Stem Cells Dev (2009) 1.05

Current developments in tissue engineering of nucleus pulposus for the treatment of intervertebral disc degeneration. Conf Proc IEEE Eng Med Biol Soc (2007) 1.02

Human intervertebral disc cells are genetically modifiable by adenovirus-mediated gene transfer: implications for the clinical management of intervertebral disc disorders. Spine (Phila Pa 1976) (2000) 1.01

Regenerative treatment strategies in spinal surgery. Front Biosci (2008) 1.00

Changes in gene expression and protein distribution at different stages of mechanically induced disc degeneration--an in vivo study on the New Zealand white rabbit. J Orthop Res (2006) 0.98

A new porcine in vivo animal model of disc degeneration: response of anulus fibrosus cells, chondrocyte-like nucleus pulposus cells, and notochordal nucleus pulposus cells to partial nucleotomy. Spine (Phila Pa 1976) (2009) 0.97

The fate of transplanted xenogeneic bone marrow-derived stem cells in rat intervertebral discs. J Orthop Res (2009) 0.96

The potential role of mesenchymal stem cell therapy for intervertebral disc degeneration: a critical overview. Neurosurg Focus (2005) 0.94

Cell therapy for disc degeneration--potentials and pitfalls. Orthop Clin North Am (2004) 0.91

Disc regeneration: why, when, and how. Neurosurg Clin N Am (2005) 0.86

Matrix metalloprotease inhibitors suppress initiation and progression of chondrogenic differentiation of mesenchymal stromal cells in vitro. Stem Cells Dev (2009) 0.86

Degeneration model of the porcine lumbar motion segment: effects of various intradiscal procedures. Eur Spine J (1994) 0.86

Use of the norepinephrine transporter as a reporter gene for non-invasive imaging of genetically modified cells. J Gene Med (2004) 0.84

Directions for future research. J Bone Joint Surg Am (2006) 0.83

Matrix-assisted cell transfer for intervertebral disc cell therapy. Biochem Biophys Res Commun (2005) 0.83

Familial incidence of intervertebral disc herniation: an hypothesis suggesting that laminectomy and discectomy may be counterproductive. J Clin Laser Med Surg (2000) 0.80

The molecular basis of intervertebral disk degeneration. Orthop Clin North Am (2003) 0.77

Percutaneous discectomy of the lumbar spine. Int Orthop (1987) 0.76

Articles by these authors

(truncated to the top 100)

Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum (2006) 4.16

Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat Biotechnol (1999) 3.97

A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci U S A (1996) 3.89

Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. Ann Neurol (1995) 3.06

Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics (2001) 3.05

Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther (2002) 2.86

Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum Genet (2001) 2.72

Crystal structure of yeast tRNAAsp. Nature (1980) 2.61

Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol Cell Biol (1998) 2.48

Oxidation of reduced inorganic sulfur compounds by bacteria: emergence of a common mechanism? Appl Environ Microbiol (2001) 2.28

Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6. Pharmacogenetics (2001) 2.08

A prognostic index for 30-day mortality after stroke. J Clin Epidemiol (2001) 2.07

Termination of ventricular fibrillation in dogs by depolarizing a critical amount of myocardium. Am J Cardiol (1975) 1.93

The future of scattered trees in agricultural landscapes. Conserv Biol (2008) 1.92

Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum (2003) 1.84

The standardization of terminology for researchers in female pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct (2001) 1.82

Induction of intervertebral disc-like cells from adult mesenchymal stem cells. Stem Cells (2005) 1.80

Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6. J Cell Physiol (2007) 1.79

Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol (1997) 1.72

Female mice respond to male ultrasonic 'songs' with approach behaviour. Biol Lett (2009) 1.71

Osteolysis in alloarthroplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles. Clin Orthop Relat Res (1990) 1.69

The ileal neobladder: complications and functional results in 363 patients after 11 years of followup. J Urol (1999) 1.69

Hounsfield unit density in the determination of urinary stone composition. Urology (2001) 1.64

A microtiter plate technique for the agglutination typing of Diplococcus pneumoniae. J Infect Dis (1970) 1.62

A comparison of two bipolar exercise electrocardiographic leads to lead V5. Chest (1976) 1.60

Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma. Biomaterials (2010) 1.58

Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res (2005) 1.57

Peroxisome biogenesis: involvement of ARF and coatomer. J Cell Biol (1998) 1.51

Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit. Genes Brain Behav (2009) 1.51

The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics (2001) 1.50

Increased number of alveolar macrophages expressing adhesion molecules of the leukocyte adhesion molecule family in smoking subjects. Association with cell-binding ability and superoxide anion production. Am Rev Respir Dis (1992) 1.49

The role of inflammation in vascular injury and repair. J Thromb Haemost (2003) 1.48

Maternal age, morphology, development and chromosome abnormalities in over 6000 cleavage-stage embryos. Reprod Biomed Online (2007) 1.47

Detection of tumours with nuclear magnetic resonance spectroscopy of plasma. Eur J Cancer Clin Oncol (1989) 1.46

The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty. Eur Heart J (2002) 1.45

Syringe size and flow rate affect drug delivery from syringe pumps. Can J Anaesth (2000) 1.45

A new method of producing chronic epileptogenic cortical foci in rats. Physiol Bohemoslov (1967) 1.43

Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage. J Cell Physiol (2009) 1.42

Infectious animal diseases: the wildlife/livestock interface. Rev Sci Tech (2002) 1.40

The location of small tumor deposits in the SLN predicts Non-SLN macrometastases in breast cancer patients. Eur J Surg Oncol (2007) 1.39

The use of mesenchymal stem cells for chondrogenesis. Injury (2008) 1.38

Reprogramming of telomerase by expression of mutant telomerase RNA template in human cells leads to altered telomeres that correlate with reduced cell viability. Mol Cell Biol (1997) 1.38

Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre. Somat Cell Mol Genet (1996) 1.35

New in vivo animal model to create intervertebral disc degeneration and to investigate the effects of therapeutic strategies to stimulate disc regeneration. Spine (Phila Pa 1976) (2002) 1.34

Porosity and pore size of beta-tricalcium phosphate scaffold can influence protein production and osteogenic differentiation of human mesenchymal stem cells: an in vitro and in vivo study. Acta Biomater (2008) 1.34

Do age- and sex-related variations reliably reflect body size in non-human primate vocalizations? A review. Primates (2007) 1.33

Computer assisted orthopaedic surgery with image based individual templates. Clin Orthop Relat Res (1998) 1.32

Validation of the brief multidimensional life satisfaction scale in patients with chronic diseases. Eur J Med Res (2009) 1.31

Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27

Enhanced expression of the human chitinase 3-like 2 gene (YKL-39) but not chitinase 3-like 1 gene (YKL-40) in osteoarthritic cartilage. Biochem Biophys Res Commun (2002) 1.27

Diagnosis and monitoring of murine histoplasmosis by a nested PCR assay. J Clin Microbiol (2001) 1.27

Detection and characterization of monoclonal antibodies specific to IgE receptors on human lymphocytes by flow cytometry. Immunology (1985) 1.23

Uptake of radiolabeled 2'-fluoro-2'-deoxy-5-iodo-1-beta-D-arabinofuranosyluracil in cardiac cells after adenoviral transfer of the herpesvirus thymidine kinase gene: the cellular basis for cardiac gene imaging. Circulation (2000) 1.22

Evidence for a preglomerular oxygen diffusion shunt in rat renal cortex. Am J Physiol (1990) 1.22

[In vivo and in vitro bone regeneration from cord blood derived mesenchymal stem cells]. Orthopade (2004) 1.21

[Cross-sectional field 14 pain medicine. Implementation of the German Pain Society (DGSS) core curriculum in the model study course MaReCuM]. Schmerz (2013) 1.21

Characterization of glycoconjugates of human gastrointestinal mucosa by lectins. I. Histochemical distribution of lectin binding sites in normal alimentary tract as well as in benign and malignant gastric neoplasms. J Histochem Cytochem (1984) 1.20

Autologous chondrocyte implantation using the original periosteum-cover technique versus matrix-associated autologous chondrocyte implantation: a randomized clinical trial. Am J Sports Med (2009) 1.19

Microtubule-based peroxisome movement. J Cell Sci (1996) 1.19

Re-evaluation of EDTA-chelated biuret reagent. Clin Chem (1974) 1.18

Telomere length and telomerase activity during expansion and differentiation of human mesenchymal stem cells and chondrocytes. J Mol Med (Berl) (2003) 1.18

Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier. Biomaterials (2005) 1.17

Osteoarthritis: cellular and molecular changes in degenerating cartilage. Prog Histochem Cytochem (2006) 1.17

Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes. Diabetes Care (1998) 1.16

Continuous in situ cold perfusion with histidine tryptophan ketoglutarate solution in nephron sparing surgery for renal tumors. J Urol (1995) 1.16

Synthetic cannabinoid and marijuana exposures reported to poison centers. Hum Exp Toxicol (2012) 1.15

The value of wildlife. Rev Sci Tech (2002) 1.15

Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in calcium phosphate ceramics. Platelets (2006) 1.14

Start-up delays of infusion syringe pumps. Paediatr Anaesth (2001) 1.14

Orbital T-cell lymphoma in human T-cell leukemia virus-I infection. Ophthalmology (1988) 1.14

Choosing a pediatric recipient for orthotopic liver transplantation. J Pediatr (1987) 1.14

Chondrogenesis of mesenchymal stem cells: role of tissue source and inducing factors. Stem Cell Res Ther (2010) 1.14

Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresis. Electrophoresis (2000) 1.14

Adenovirus-mediated gene transfer of growth and differentiation factor-5 into tenocytes and the healing rat Achilles tendon. Connect Tissue Res (2005) 1.13

Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6. Pharmacogenetics (2000) 1.13

Negroes and whites and rates of mental illness: reconsideration of a myth. Psychiatry (1969) 1.13

Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group. J Clin Oncol (1985) 1.12

Central venous cannulation: A radiological determination of catheter positions and immediate intrathoracic complications. Acta Anaesthesiol Scand (1977) 1.12

Osteolysis in alloarthroplasty of the hip. The role of bone cement fragmentation. Clin Orthop Relat Res (1990) 1.11

Clinical outcomes assessment in multiple sclerosis. Ann Neurol (1996) 1.11

FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities. Oncogene (2008) 1.11

Stimulation of gene expression and loss of anular architecture caused by experimental disc degeneration--an in vivo animal study. Spine (Phila Pa 1976) (2005) 1.11

Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood (1998) 1.10

Break-up of the Atlantic deep western boundary current into eddies at 8 degrees S. Nature (2004) 1.09

Early and stable upregulation of collagen type II, collagen type I and YKL40 expression levels in cartilage during early experimental osteoarthritis occurs independent of joint location and histological grading. Arthritis Res Ther (2004) 1.09

Fecal blood loss in patients with colonic polyps: a comparison of measurements with 51chromium-labeled erythrocytes and with the Haemoccult test. Gastroenterology (1982) 1.09

CB1-cannabinoid and mu-opioid receptor co-localization on postsynaptic target in the rat dorsal horn. Neuroreport (2001) 1.09

Laboratory diagnosis of central nervous system infections. Infect Dis Clin North Am (2001) 1.09

Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy. Endoscopy (2006) 1.08

Shape and specificity in mammalian 15-lipoxygenase active site. The functional interplay of sequence determinants for the reaction specificity. J Biol Chem (1999) 1.08

Reduced reactivation from dormancy but maintained lineage choice of human mesenchymal stem cells with donor age. PLoS One (2011) 1.08

Introgressive hybridization in southern African baboons shapes patterns of mtDNA variation. Am J Phys Anthropol (2010) 1.08

Emerging infectious diseases in wildlife. Rev Sci Tech (2002) 1.08

L-2-hydroxyglutaric aciduria and brain tumors in children with mutations in the L2HGDH gene: neuroimaging findings. Neuropediatrics (2008) 1.08

Chondrogenesis of mesenchymal stem cells in gel-like biomaterials in vitro and in vivo. Front Biosci (2008) 1.07

Experience with carbon-11 choline positron emission tomography in prostate carcinoma. Eur J Nucl Med (2000) 1.07

Release of active and depot GDF-5 after adenovirus-mediated overexpression stimulates rabbit and human intervertebral disc cells. J Mol Med (Berl) (2003) 1.07

Electrophysiological properties of the epileptogenic cortical foci produced by a new cobalt-gelatine method in rats an attempt to correlate the electrophysiological, histological and histochemical data. Physiol Bohemoslov (1967) 1.07

Structure-activity relationships of 2-(1H-imidazol-1-yl)vinyl ethers. Route to the new broad-spectrum antifungal agent omoconazole. Ann N Y Acad Sci (1988) 1.07

Usefulness of GOLD classification of COPD severity. Thorax (2003) 1.06